Literature DB >> 31707643

Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.

Katsusuke Yamamoto1,2, Yasuhiro Hasegawa1, Yasuhisa Ohata1,3, Kenichi Satomura2,4, Yoshimi Mizoguchi1, Tsunesuke Shimotsuji1, Takehisa Yamamoto5.   

Abstract

The oculocerebrorenal disorder of Lowe syndrome is an X-linked mutation in the gene oculocerebrorenal syndrome of Lowe 1 (OCRL), characterized by the triad of congenital cataracts, severe intellectual impairment, and renal tubular dysfunction. Manifestations of phenotype in female carriers and patients are extremely rare. We present a female case with congenital cataracts, severe intellectual impairment, sensorineural hearing loss, and renal tubular dysfunction as Lowe syndrome. A 9-year-old Japanese girl visited our hospital due to prolonged proteinuria. Her renal biopsy revealed diffuse mesangium proliferation, sclerosis and dilatation of renal tubules, and mild IgA deposition in the mesangial region. Furthermore, she had congenital cataracts, severe intellectual impairment, and sensorineural hearing loss. Genetic screening did not identify mutations of the ORCL gene encoding inositol polyphosphate 5-phosphatase (IPP-5P) (46 XX, female). However, we found the reduction of enzyme activity of IPP-5P to 50% of the normal value. Furthermore, her renal function had deteriorated to renal failure within a decade. Finally, she received peritoneal dialysis and renal transplantation. We present the oculocerebrorenal phenotype of Lowe syndrome in a female patient with reduced activity of IPP-5P without OCRL gene mutation.

Entities:  

Keywords:  Inositol polyphosphate 5-phosphatase; Lowe syndrome; OCRL gene; Oculocerebrorenal; Renal tubular dysfunction

Mesh:

Substances:

Year:  2019        PMID: 31707643      PMCID: PMC7148414          DOI: 10.1007/s13730-019-00434-z

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  20 in total

1.  End-stage renal failure in Lowe syndrome.

Authors:  Leila Tricot; Yasmina Yahiaoui; Luis Teixeira; Leila Benabdallah; Eugene Rothschild; Jean-Pierre Juquel; Veronique Satre; Jean-Pierre Grünfeld; Dominique Chauveau
Journal:  Nephrol Dial Transplant       Date:  2003-09       Impact factor: 5.992

2.  From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes.

Authors:  Haifa Hichri; John Rendu; Nicole Monnier; Charles Coutton; Olivier Dorseuil; Rosa Vargas Poussou; Geneviève Baujat; Anne Blanchard; François Nobili; Bruno Ranchin; Michel Remesy; Rémi Salomon; Véronique Satre; Joel Lunardi
Journal:  Hum Mutat       Date:  2011-03-10       Impact factor: 4.878

3.  Increased risk of end-stage renal disease in familial IgA nephropathy.

Authors:  Francesco Paolo Schena; Giuseppina Cerullo; Michele Rossini; Salvatore Giovanni Lanzilotta; Christian D'Altri; Carlo Manno
Journal:  J Am Soc Nephrol       Date:  2002-02       Impact factor: 10.121

Review 4.  Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL.

Authors:  Michelle Pirruccello; Pietro De Camilli
Journal:  Trends Biochem Sci       Date:  2012-02-28       Impact factor: 13.807

5.  Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease.

Authors:  Osamu Uemura; Takuhito Nagai; Kenji Ishikura; Shuichi Ito; Hiroshi Hataya; Yoshimitsu Gotoh; Naoya Fujita; Yuko Akioka; Tetsuji Kaneko; Masataka Honda
Journal:  Clin Exp Nephrol       Date:  2013-09-07       Impact factor: 2.801

6.  Oculocerebrorenal syndrome in a female child.

Authors:  J Svorc; J Masopust; A Komárková; M Macek; J Hyánek
Journal:  Am J Dis Child       Date:  1967-08

Review 7.  Lowe syndrome/Dent-2 disease: A comprehensive review of known and novel aspects.

Authors:  Florian Recker; Heiko Reutter; Michael Ludwig
Journal:  J Pediatr Genet       Date:  2013-06

8.  Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy.

Authors:  Lorenzo Monserrat; Juan Ramón Gimeno-Blanes; Francisco Marín; Manuel Hermida-Prieto; Antonio García-Honrubia; Inmaculada Pérez; Xusto Fernández; Rosario de Nicolas; Gonzalo de la Morena; Eduardo Payá; Jordi Yagüe; Jesús Egido
Journal:  J Am Coll Cardiol       Date:  2007-12-18       Impact factor: 24.094

9.  Lowe oculocerebrorenal syndrome in a female with a balanced X;20 translocation: mapping of the X chromosome breakpoint.

Authors:  O T Mueller; J K Hartsfield; L A Gallardo; Y P Essig; K L Miller; P R Papenhausen; T A Tedesco
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

10.  Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus.

Authors:  S F Suchy; I M Olivos-Glander; R L Nussabaum
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.